MedTrace Logo

The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study

NCT03152292 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 764

Last updated 2021-08-06

No results posted yet for this study

Summary

To examine the current disease progression of PDP, the clinical, economic, and humanistic impact of anti-psychotic therapy in the management of the condition in real-world settings, and the burden of the condition on patients and their caregivers

Conditions

  • Parkinson Disease Psychosis

Interventions

OTHER

Real-world, non-interventional

N/A - non-interventional

Sponsors & Collaborators

  • ACADIA Pharmaceuticals Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-30
Primary Completion
2021-03-08
Completion
2021-03-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03152292 on ClinicalTrials.gov